pyrroles has been researched along with makaluvamine a in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imai, S; Ishibashi, M; Ito, A; Iwasaki, T; Sakamoto, S; Yamaguchi, K | 1 |
Fan, L; Raisch, KP; Shinkre, BA; Velu, SE | 1 |
Murugesan, S; Nadkarni, DH; Rayburn, ER; Velu, SE; Wang, W; Zhang, R | 1 |
Boucle, S; Clastre, M; Guillard, J; Melin, C | 1 |
4 other study(ies) available for pyrroles and makaluvamine a
Article | Year |
---|---|
Laboratory culture of the myxomycetes: formation of fruiting bodies of Didymium bahiense and its plasmodial production of Makaluvamine A.
Topics: Animals; Chromatography, Thin Layer; Magnetic Resonance Spectroscopy; Myxomycetes; Porifera; Pyrroles; Quinolones; Spores, Fungal | 2001 |
Analogs of the marine alkaloid makaluvamines: synthesis, topoisomerase II inhibition, and anticancer activity.
Topics: Alkaloids; Amsacrine; Animals; Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; Humans; Marine Biology; Molecular Structure; Pyrroles; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2007 |
In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Molecular Structure; Pyrroles; Quinolones; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2009 |
Design, synthesis and evaluation of new marine alkaloid-derived pentacyclic structures with anti-tumoral potency.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Drug Design; HCT116 Cells; Humans; Molecular Structure; Pyrroles; Quinolones; Topoisomerase II Inhibitors | 2015 |